Basu S

No ORCID on file · 4 papers in corpus
2026
Frontiers in oncology ·doi:10.3389/fonc.2026.1818655

Current anti-angiogenic therapies using vascular endothelial growth factor-A/vascular endothelial growth factor receptor-2 (VEGF-A/VEGFR2) inhibitors lack dynamic biomarkers that can facilitate patient selection and optimize dosing; this ca…

2024
Microbial biotechnology ·doi:10.1111/1751-7915.70055

Phthalic acid esters (PAEs), the pervasive and ubiquitous endocrine-disrupting chemicals of environmental concern, generated annually on a million-ton scale, are primarily employed as plasticisers in the production of a variety of plastic p…

article 2023
Journal of Human Reproductive Sciences ·doi:10.4103/jhrs.jhrs_28_23

BACKGROUND: In practice, we encounter many young infertile women with poor ovarian reserve though ovarian reserve starts to decline after 35 years of age. One of the established risk factors for poor ovarian reserve in young women is endome…

2015
Lancet (London, England) ·doi:10.1016/s0140-6736(15)61340-x

BackgroundThe Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable compariso…